Alliance digital tool proves effective at keeping patients engaged in trials
Peer-Reviewed Publication
Updates every hour. Last Updated: 18-Jun-2026 09:16 ET (18-Jun-2026 13:16 GMT/UTC)
The number of patients living with neurodegenerative diseases that affect movement is rising steadily. Yet a large-scale study from the Paris Brain Institute and the Karolinska Institutet in Stockholm shows that this is not an emerging health crisis: the trend conceals very different realities, with direct implications for public health policy and research. The findings are published in Neurology.
The horses at the Children’s Zoo in Gothenburg don’t mind being pet by children and adults. However, they do get stressed by the noise from an excavator. Researchers at the University of Gothenburg have discovered this after fitting heart rate monitors to eight Gotland russ horses.
Infections should be considered a “health hazard” in people living with diabetes, with experts warning that current clinical guidelines fail to reflect a substantial but under-recognised burden of illness, hospitalisation and death. This is according to a major study published today in Diabetes and presented at the American Diabetes Association Scientific Sessions conference in New Orleans.
Though several randomized controlled trials have investigated the effects of ultraprocessed foods (UPF) on obesity, leading to news coverage that suggests ultraprocessing is inherently harmful, the reality is different, according to the authors of this Perspective. Based on the design of clinical trials conducted to date, it is very difficult to attribute negative effects observed in trial participants to ultraprocessing. Instead, these effects are likely due to differences in traditional nutritional properties that UPFs frequently exhibit – including soft textures (which can lead people to eat more and faster), high calorie density, high amounts of saturated fat and salt, and low fiber and protein content. These properties affect health regardless of the extent of food processing, Faidon Magkos and colleagues say. The authors describe the five clinical trials conducted so far on UPFs in the USA, UK, Denmark, and Japan, outlining the trials’ methods, variable findings, and limitations. “Collectively, available randomized controlled trials provide weak support for an ultraprocessing-specific effect of UPFs on body weight regulation and cardiometabolic function that is independent of established nutritional determinants,” Magkos et al. write. They note that the UPF concept encompasses many foods that are unhealthy, but also foods that are not necessarily harmful and even some that are beneficial. Based on evidence from the trials, they recommend that policy guidance around UPFs should focus on distinguishing nutritionally poor, calorie-dense, and rapidly consumed foods – regardless of their degree of processing.
Podcast: A segment of Science's weekly podcast with Faidon Magkos, related to this research, will be available on the Science.org podcast landing page after the embargo lifts. Reporters are free to make use of the segments for broadcast purposes and/or quote from them – with appropriate attribution (i.e., cite "Science podcast"). Please note that the file itself should not be posted to any other Web site.